Patents by Inventor George W. Sledge

George W. Sledge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VEGF polymorphisms and anti-angiogenesis therapy
    Patent number: 10031141
    Abstract: Methods for determining whether a patient in at particular risk of hypertension associated with anti-VEGF treatment or has a greater likelihood of benefiting from anti-VEGF therapy by screening a sample isolated from the patient for specific genomic polymorphisms.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: July 24, 2018
    Assignee: Genentech, Inc.
    Inventors: Bryan P. Schneider, Milan Radovich, George W. Sledge
  • Method to treat cancer with tetracyclines
    Patent number: 5668122
    Abstract: The present invention provides a method to treat susceptible cancers in humans comprising administering a cancer-treating amount of a member of the tetracycline family or a pharmaceutically acceptable salt thereof. Doxycycline, minocycline and tetracycline are utilized in the preferred method. Preferred methods of the present invention treat osteo-, breast, lung, prostate or Kaposi's cancers. Other aspects of the invention are described in the full application.
    Type: Grant
    Filed: May 1, 1995
    Date of Patent: September 16, 1997
    Inventors: Rose S. Fife, George W. Sledge